Fig. 3From: SUPREME-HN: a retrospective biomarker study assessing the prognostic value of PD-L1 expression in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neckMultivariable analysis of risk factors for OS. aPatients with OS data n = 370, patients with PD-L1 result n = 355Back to article page